Showing results (811-820 of 857) with videos related to
Sort By:
Pageof 86
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trialPiero Ruggenenti, Giuseppe Lauria, Ilian Petrov Iliev, et al.Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.Journal of the American Society of Nephrology : JASN|August 10, 2023
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)Norberto Perico, Giuseppe Remuzzi, Matthew D Griffin, et al.JAMA|August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Hong Zhang, Muh Geot Wong, et al.The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.JAMA|May 17, 2022
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Muh Geot Wong, Michelle A Hladunewich, et al.Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2024
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complementFei Liu, Sarah T Ryan, Kelly C Fahnoe, et al.Pageof 86